ESC 365 - Cardiovascular events and consequent risk of death in hematopoietic stem cell transplant recipients

ESC Professional Premium Access

Cardiovascular events and consequent risk of death in hematopoietic stem cell transplant recipients

Session: Caring for the patient with cancer and heart disease: the clinical perspective

Topic: Cardio-Oncology

Speaker: Doctor G. Stronati (Ancona, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Giulia Stronati

Marche Polytechnic University of Ancona, Ancona (Italy)

2 followers

7 more presentations in this session

Socioeconomic status and cardiovascular mortality in over 170,000 cancer survivors: a population-based cohort study

Speaker: Doctor Y. Kim (Seoul, KR)

Routine application of cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy

Speaker: Mr T. Lerchner (Essen, DE)

Safety and effectiveness of sodium-glucose co-transporter 2 inhibitors in active cancer patients with heart failure: results of the observational TOSCA trial

Speaker: Doctor M. Canale (Lido Di Camaiore, IT)

Cardiological monitoring during BTK inhibitor, ICI, and RAF/MEK inhibitor therapy: the single-center prospective registry for cardiovascular events under new cancer therapies (RECENT)

Speaker: Doctor L. Seuthe (Cologne, DE)

New onset of left ventricular dysfunction and diastolic dysfunction are uncommon in patients with her2+ breast cancer after completion of cancer therapy.

Speaker: Doctor N. Osataphan (Chiang Mai, TH)

Access the full session

Caring for the patient with cancer and heart disease: the clinical perspective

Speakers: Doctor G. Stronati, Doctor Y. Kim, Mr T. Lerchner, Doctor M. Canale, Doctor L. Seuthe...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources